Onconetix, Inc. (ONCO)
3.15
+0.15
(+5.00%)
USD |
NASDAQ |
Nov 18, 16:00
3.15
0.00 (0.00%)
After-Hours: 19:58
Onconetix EPS Diluted (Quarterly) : -12.78 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -12.78 |
| March 31, 2026 | -670.60 |
| December 31, 2025 | 1817.20 |
| September 30, 2025 | -3124.83 |
| June 30, 2025 | -2379.07 |
| March 31, 2025 | -22717.95 |
| December 31, 2024 | -107184.6 |
| September 30, 2024 | -124537.8 |
| June 30, 2024 | -1.096M |
| March 31, 2024 | -853434.0 |
| December 31, 2023 | -1.702M |
| September 30, 2023 | -518772.0 |
| Date | Value |
|---|---|
| June 30, 2023 | -733720.0 |
| March 31, 2023 | -304164.0 |
| December 31, 2022 | -358360.0 |
| September 30, 2022 | -458439.0 |
| June 30, 2022 | -604367.0 |
| March 31, 2022 | -581111.0 |
| December 31, 2021 | -210409.0 |
| September 30, 2021 | -197302.0 |
| March 31, 2021 | -246211.0 |
| December 31, 2020 | -83878.00 |
| September 30, 2020 | -73100.00 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Vistagen Therapeutics, Inc. | -0.2417 |
| BridgeBio Pharma, Inc. | -0.4234 |
| ACADIA Pharmaceuticals, Inc. | 0.305 |
| Alnylam Pharmaceuticals, Inc. | 15.72 |
| Anika Therapeutics, Inc. | -0.0232 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.867M |
| Revenue (Quarterly) | 0.0171M |
| Total Expenses (Quarterly) | 2.884M |
| Enterprise Value | -4.615M |
| Gross Profit Margin (Quarterly) | 25.15% |
| Profit Margin (Quarterly) | -16.77K% |
| Earnings Yield | -63.21K% |
| Normalized Earnings Yield | -80897.75 |